Trial Details

RECRUITING
Basic Information
Clinical ID c91
Identifier NCT06274294
Trial Title Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: CT-P13
Participant Information
Sponsor CMC Ambroise Par
City Neuilly-sur-Seine
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2024-07-10
Primary Completion Date 2025-01-25
Completion Date 2025-01-25